Glutamate hypothesis in schizophrenia DOI Open Access
Yota Uno, Joseph T. Coyle

Psychiatry and Clinical Neurosciences, Journal Year: 2019, Volume and Issue: 73(5), P. 204 - 215

Published: Jan. 22, 2019

Schizophrenia is a chronic and severe psychiatric disorder that has profound impact on an individual's life society. Thus, developing more effective therapeutic interventions essential. Over the past quarter-century, abundance of evidence from pharmacologic challenges, post-mortem studies, brain imaging, genetic studies supports role glutamatergic dysregulation in pathophysiology schizophrenia, results recent randomized clinical trials based this have yielded promising results. In article, we review alterations neurotransmission, especially focusing N-methyl-d-aspartate receptor (NMDAR) function, may be critical causative feature how contributes to pathologic circuit function brain, these insights are revealing whole new avenues for treatment development could reduce treatment-resistant symptoms, which account persistent disability.

Language: Английский

Mechanisms and Therapeutic Relevance of Neuro-immune Communication DOI Creative Commons
Sangeeta S. Chavan, Valentin A. Pavlov, Kevin J. Tracey

et al.

Immunity, Journal Year: 2017, Volume and Issue: 46(6), P. 927 - 942

Published: June 1, 2017

Language: Английский

Citations

536

Interplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlight DOI
Yang Shi, David M. Holtzman

Nature reviews. Immunology, Journal Year: 2018, Volume and Issue: 18(12), P. 759 - 772

Published: Aug. 23, 2018

Language: Английский

Citations

502

Blood GFAP as an emerging biomarker in brain and spinal cord disorders DOI Open Access
Ahmed Abdelhak, Matteo Foschi, Samir Abu‐Rumeileh

et al.

Nature Reviews Neurology, Journal Year: 2022, Volume and Issue: 18(3), P. 158 - 172

Published: Feb. 3, 2022

Language: Английский

Citations

474

Glial Cells: Role of the Immune Response in Ischemic Stroke DOI Creative Commons
Shenbin Xu, Jianan Lü, Anwen Shao

et al.

Frontiers in Immunology, Journal Year: 2020, Volume and Issue: 11

Published: Feb. 26, 2020

Ischemic stroke, which accounts for 75-80% of strokes, is a predominant cause morbidity and mortality worldwide. Recently, post-stroke immune response becomes new breakthrough the treatment strategy ischemic stroke. Glial cells, including microglia, astrocytes, oligodendrocytes, are major components peri-infarction environment in central nervous system have been elucidated to play critical roles regulation. However, increasing evidences suggest that glial cells exert different, even contrary effect Microglia, survey CNS homostasis regulate innate response, rapidly activated following The microglia would release inflammatory cytokines induce neuronal tissue injuries. On contrary, anti-inflammatory neurotrophic factors secreted by alternatively considered be benefit recovery Astrocytes activation reactive gliosis stroke contribute limitaion brain injury stabalize homeostasis. scar developed astrocytes also hinder reconnectivity extension. Oligodendrocytes shown extensively involved demyelination remyelination after Oligodendrocyte precursor able differentiate into reactived supposed lead functional recovery. Here we discuss mechanisms regulation mediated interaction between neurons. present review, from perspective various describes their possible at different stages future intervention targets.

Language: Английский

Citations

464

Inflammation: the link between comorbidities, genetics, and Alzheimer’s disease DOI Creative Commons
Estella A. Newcombe, Judith Camats‐Perna,

Mallone L. Silva

et al.

Journal of Neuroinflammation, Journal Year: 2018, Volume and Issue: 15(1)

Published: Sept. 24, 2018

Alzheimer’s disease (AD) is a neurodegenerative disorder, most cases of which lack clear causative event. This has made the difficult to characterize and, thus, diagnose. Although some are genetically linked, there many diseases and lifestyle factors that can lead an increased risk developing AD, including traumatic brain injury, diabetes, hypertension, obesity, other metabolic syndromes, in addition aging. Identifying common trends between these conditions could enhance our understanding AD development more effective treatments. immune system one body’s key defense mechanisms, chronic inflammation been increasingly linked with several age-related diseases. Moreover, it now well accepted important role onset progression AD. In this review, different inflammatory signals associated its will be outlined demonstrate how may influencing individual susceptibility Our goal bring attention potential shared presented by during successful

Language: Английский

Citations

458

Neurotoxic reactive astrocytes induce cell death via saturated lipids DOI
Kevin A. Guttenplan, Maya K. Weigel, Priya Prakash

et al.

Nature, Journal Year: 2021, Volume and Issue: 599(7883), P. 102 - 107

Published: Oct. 6, 2021

Language: Английский

Citations

434

Neuroinflammatory astrocyte subtypes in the mouse brain DOI
Philip Hasel, Indigo V.L. Rose, Jessica S. Sadick

et al.

Nature Neuroscience, Journal Year: 2021, Volume and Issue: 24(10), P. 1475 - 1487

Published: Aug. 19, 2021

Language: Английский

Citations

424

Aging and age‐related diseases: from mechanisms to therapeutic strategies DOI Open Access
Zhe Li, Zhenkun Zhang,

Yikun Ren

et al.

Biogerontology, Journal Year: 2021, Volume and Issue: 22(2), P. 165 - 187

Published: Jan. 27, 2021

Language: Английский

Citations

412

Interaction of Microglia and Astrocytes in the Neurovascular Unit DOI Creative Commons
Lirong Liu, Jiachen Liu,

Jin-shuang Bao

et al.

Frontiers in Immunology, Journal Year: 2020, Volume and Issue: 11

Published: July 8, 2020

The interaction between microglia and astrocytes significantly influences neuroinflammation. Microglia/astrocytes, part of the neurovascular unit (NVU), are activated by various brain insults. local extracellular intracellular signals determine their characteristics switch phenotypes. Microglia into two polarization states: pro-inflammatory phenotype (M1 A1) anti-inflammatory (M2 A2). During neuroinflammation, induced stroke or lipopolysaccharides, more sensitive to pathogens damage, thus initially M1 phenotype, produce common inflammatory such as IL- 1 TNF-α trigger reactive A1 phenotype. These can be amplified not only self-feedback loop microglial activation, but also unique anatomy structure astrocytes. As pathology further progresses, resulting in environmental changes, M1-like M2 crosstalk with A2. While communicate simultaneously neurons blood vessels maintain function blood-brain barrier (BBB), subtle changes may identified responded astrocytes, possibly transferred microglia. Although both have different functional characteristics, they achieve immune "optimization" through mutual communication cooperation NVU build a cascaded network amplification.

Language: Английский

Citations

411

MAFG-driven astrocytes promote CNS inflammation DOI
Michael A. Wheeler, Iain C. Clark,

Emily Tjon

et al.

Nature, Journal Year: 2020, Volume and Issue: 578(7796), P. 593 - 599

Published: Feb. 12, 2020

Language: Английский

Citations

382